Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/29715

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorCastaño, Julioes
dc.contributor.authorDavalos, Verónicaes
dc.contributor.authorSchwartz Jr., Simo-
dc.contributor.authorArango, Diego-
dc.date.accessioned2013-01-18T13:36:14Z-
dc.date.available2013-01-18T13:36:14Z-
dc.date.issued2008-
dc.identifier.issn0213-3911es
dc.identifier.urihttp://hdl.handle.net/10201/29715-
dc.description.abstractEPH receptors and their ephrin ligands constitute the largest sub-family of receptor tyrosine kinases (RTKs) and are components of cell signaling pathways involved in animal development. The ability of the EPH/ephrin guidance system to position cells and modulate cell morphology underlies their various roles in development. In addition, EPH signaling plays an important role in oncogenic processes observed in several organs. These receptors are involved in a wide range of processes directly related with tumorigenesis and metastasis, including cell attachment and shape, migration, and angiogenesis. Accordingly, deregulation of EPH expression and signaling activity could be crucial for the tumorigenic process. This review focuses on EPH receptors’ roles in oncogenic transformation and tumor progression.es
dc.formatapplication/pdfes
dc.format.extent13es
dc.languageenges
dc.publisherMurcia : F. Hernándezes
dc.relation.ispartofHistology and histopathologyes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectTumorigenesises
dc.subjectCanceres
dc.subject.other616 - Patología. Medicina clínica. Oncologíaes
dc.titleEPH receptors in canceres
dc.typeinfo:eu-repo/semantics/articlees
Aparece en las colecciones:Vol.23, nº8 (2008)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
EPH receptors in cancer.pdf1,49 MBAdobe PDFVista previa
Visualizar/Abrir


Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.